Emron Managed Care News 5-8-15

FDA clears The Medicines Company’s Raplixa, Ionsys

The FDA approved The Medicines Company’s Raplixa (fibrin sealant) as the first spray-dried fibrin sealant cleared in the US to help control bleeding during surgery, the company announced. The biological product is approved for use in adults to help control bleeding from small blood vessels when standard surgical techniques are ineffective or impractical.

Insulin Inhaler Afrezza Flops in Market Debut

The future of MannKind looks bleak in the wake of poor sales of the firm’s much anticipated flagship product.

Cancer drug spending tops $100 billion, up 10% in a year

As drug prices continue to fall under ever-increasing scrutiny, spending on cancer medicines has hit a new milestone: $100 billion in 2014.

New ovarian cancer screening method can detect twice as many cases

Researchers say they’ve developed a new screening method that can detect ovarian cancer in twice as many women as traditional strategies.

Scientists find new link between diabetes and Alzheimer’s

Researchers have uncovered a unique connection between diabetes and Alzheimer’s disease, providing further evidence that a disease that robs people of their memories may be affected by elevated blood sugar, according to scientists at Washington University School of Medicine in St. Louis.

Statins May Slow Prostate Cancer Progression: Study

Statins, widely used to lower cholesterol levels, may also slow the progression of prostate cancer in patients  receiving hormone therapy, a new study suggests.

Many Women Unaware of Female-Specific Stroke Symptoms

Stroke is the third leading cause of death in women, but many are unaware of warning signs and symptoms that are unique to females, a new study says.

WHO adds new hepatitis C, cancer drugs to essential medicines list

The World Health Organization on Friday said that it added a number of new treatments for hepatitis C to its essential medicines list, although the agency noted that “high prices currently make them unaffordable and thus inaccessible to most people who need them.” The WHO also included new drugs for a variety of cancers, including breast cancer and leukaemia, and multi-drug resistant tuberculosis on its list.

HHS will expand Pioneer ACO program

The Centers for Medicare & Medicaid Services’ Pioneer Accountable Care Organization (ACO) program saved nearly $400 million in two years, qualifying it for an expansion, the Department of Health and Human Services announced this week.

High-Protein Diet May Be Dangerous for Those at Risk of Heart Disease

A high-protein diet may backfire for people at risk for heart disease — increasing the likelihood of weight gain and early death, a new study suggests.

Roche leukemia drug gets FDA therapy designation

The U.S. Food and Drug Administration has granted breakthrough therapy designation to a Roche Holding AG (RO.EB) leukemia drug, speeding the regulatory review process for the therapy.